Explore the discovery of AZD0364, a potent ERK1/2 inhibitor showing promise in treating resistant non-small cell lung cancer through targeted molecular therapy.
Explore how aspergillosis, a fungal infection, can mimic lung cancer in diagnosis, symptoms, and imaging, creating significant challenges for clinicians.
Discover how organic aerosol coatings shield polycyclic aromatic hydrocarbons (PAHs), increasing their long-range transport and lung cancer risk worldwide.
Discover how photoacoustic imaging and glutathione targeting are transforming lung cancer diagnosis and treatment with unprecedented precision.